|
1
|
Di Stefano G, Fiume L, Bolondi L, Lanza M,
Pariali M and Chieco P: Enhanced uptake of lactosaminated human
albumin by rat hepatocarcinomas: Implications for an improved
chemotherapy of primary liver tumors. Liver Int. 25:854–860. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mann CD, Neal CP, Garcea G, Manson MM,
Dennison AR and Berry DP: Phytochemicals as potential
chemopreventive and chemotherapeutic agents in
hepatocarcinogenesis. Eur J Cancer Prev. 18:13–25. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Glauert HP, Calfee-Mason K, Stemm DN,
Tharappel JC and Spear BT: Dietary antioxidants in the prevention
of hepatocarcinogenesis: a review. Mol Nutr Food Res. 54:875–896.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lim DY, Jeong Y, Tyner AL and Park JH:
Induction of cell cycle arrest and apoptosis in HT-29 human colon
cancer cells by the dietary compound luteolin. Am J Physiol
Gastrointest Liver Physiol. 292:G66–G75. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cheng YL, Chang WL, Lee SC, Liu YG, Chen
CJ, Lin SZ, Tsai NM, Yu DS, Yen CY and Harn HJ: Acetone extract of
Angelica sinensis inhibits proliferation of human cancer cells via
inducing cell cycle arrest and apoptosis. Life Sci. 75:1579–1594.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Baliga MS, Meleth S and Katiyar SK: Growth
inhibitory and antimetastatic effect of green tea polyphenols on
metastasis-specific mouse mammary carcinoma 4T1 cells in vitro and
in vivo systems. Clin Cancer Res. 11:1918–1927. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Michaud DS, Feskanich D, Rimm EB, Colditz
GA, Speizer FE, Willett WC and Giovannucci E: Intake of specific
carotenoids and risk of lung cancer in 2 prospective US cohorts. Am
J Clin Nutr. 72:990–997. 2000.PubMed/NCBI
|
|
9
|
Kim ND, Mehta R, Yu W, Neeman I, Livney T,
Amichay A, Poirier D, Nicholls P, Kirby A, Jiang W and Mansel R:
Chemopreventive and adjuvant therapeutic potential of pomegranate
(Punica granatum) for human breast cancer. Breast Cancer Res Treat.
71:203–217. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang SF, Yang WE, Chang HR, Chu SC and
Hsieh YS: Luteolin induces apoptosis in oral squamous cancer cells.
J Dental Res. 87:401–406. 2008. View Article : Google Scholar
|
|
11
|
Pistollato F, Giampieri F and Battino M:
The use of plant-derived bioactive compounds to target cancer stem
cells and modulate tumor microenvironment. Food Chem Toxicol.
75:58–70. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Schuller-Levis G, Mehta PD, Rudelli R and
Sturman J: Immunologic consequences of taurine deficiency in cats.
J Leukoc Biol. 47:321–331. 1990.PubMed/NCBI
|
|
13
|
Lake N, Wright ED and Lapp WS: Effects of
taurine deficiency on immune function in mice. Adv Exp Med Biol.
315:241–243. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bustamante J, Lobo MV, Alonso FJ, Mukala
NT, Giné E, Solís JM, Tamarit-Rodriguez J and Del Río R Martín: An
osmotic-sensitive taurine pool is localized in rat pancreatic islet
cells containing glucagon and somatostatin. Am J Physiol Endocrinol
Metab. 281:E1275–E1285. 2001.PubMed/NCBI
|
|
15
|
Miyazaki T, Karube M, Matsuzaki Y, Ikegami
T, Doy M, Tanaka N and Bouscarel B: Taurine inhibits oxidative
damage and prevents fibrosis in carbon tetrachloride-induced
hepatic fibrosis. J Hepatol. 43:117–125. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tasci I, Mas MR, Vural SA, Deveci S,
Comert B, Alcigir G, Mas N, Akay C, Bozdayi M, Yurdaydim C, et al:
Pegylated interferon-alpha plus taurine in treatment of rat liver
fibrosis. World J Gastroenterol. 13:32372007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tasci I, Mas N, Mas MR, Tuncer M and
Comert B: Ultrastructural changes in hepatocytes after taurine
treatment in CCl4 induced liver injury. World J Gastroenterol.
14:48972008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cetiner M, Sener G, Sehirli AO,
Ekşioğlu-Demiralp E, Ercan F, Sirvanci S, Gedik N, Akpulat S,
Tecimer T and Yeğen BC: Taurine protects against
methotrexate-induced toxicity and inhibits leukocyte death. Toxicol
Appl Pharmacol. 209:39–50. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Alam SS, Hafiz NA and Abd El-Rahim AH:
Protective role of taurine against genotoxic damage in mice treated
with methotrexate and tamoxfine. Environ Toxicol Pharmacol.
31:143–152. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Akay C, Yaman H, Oztosun M, Cakir E,
Yildirim AO, Eyi YE, Agilli M, Akgul EO, Aydin I, Kaldirim U, et
al: The protective effects of taurine on experimental acute
pancreatitis in a rat model. Hum Exp Toxicol. 32:522–529. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tu S, Zhang X, Luo D, Liu Z, Yang X, Wan
H, Yu L, Li H and Wan F: Effect of taurine on the proliferation and
apoptosis of human hepatocellular carcinoma HepG2 cells. Exp Ther
Med. 10:193–200. 2015.PubMed/NCBI
|
|
22
|
Zhang X, Tu S, Wang Y, Xu B and Wan F:
Mechanism of taurine-induced apoptosis in human colon cancer cells.
Acta Biochim Biophys Sin (Shanghai). 46:261–272. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tu S, Zhang X, Luo D, Liu Z, Yang X, Wan
H, Yu L, Li H and Wan F: Effect of taurine on the proliferation and
apoptosis of human hepatocellular carcinoma HepG2 cells. Exp Ther
Med. 10:193–200. 2015.PubMed/NCBI
|
|
24
|
Punithavathi D, Venkatesan N and Babu M:
Curcumin inhibition of bleomycin-induced pulmonary fibrosis in
rats. Br J Pharmacol. 131:169–172. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kim KA, Lee WJ, Lim HK, Park CM, Park CK,
Cha IH and Seol HY: Small hepatocellular carcinoma:
Ultrasonographic findings and histopathologic correlation. Clin
Imaging. 27:340–345. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Duvoix A, Blasius R, Delhalle S,
Schnekenburger M, Morceau F, Henry E, Dicato M and Diederich M:
Chemopreventive and therapeutic effects of curcumin. Cancer Lett.
223:181–190. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gulcubuk A, Altunatmaz K, Sonmez K,
Haktanir-Yatkin D, Uzun H, Gurel A and Aydin S: Effects of curcumin
on tumour necrosis factor-alpha and interleukin-6 in the late phase
of experimental acute pancreatitis. J Vet Med A Physiol Pathol Clin
Med. 53:49–54. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chuang SE, Kuo ML, Hsu CH, Chen CR, Lin
JK, Lai GM, Hsieh CY and Cheng AL: Curcumin-containing diet
inhibits diethylnitrosamine-induced murine hepatocarcinogenesis.
Carcinogenesis. 21:331–335. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Huang MT, Newmark HL and Frenkel K:
Inhibitory effects of curcumin on tumorigenesis in mice. J Cell
Biochem Suppl. 27:26–34. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Subramanian M, Sreejayan, Rao MN,
Devasagayam TP and Singh BB: Diminution of singlet oxygen-induced
DNA damage by curcmin and related antioxidants. Mutat Res.
311:249–255. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Parshad R, Sanford KK, Price FM, Steele
VE, Tarone RE, Kelloff GJ and Boone CW: Protective action of plant
polyphenols on radiation-induced chromatid breaks in cultured human
cells. Anticancer Res. 18:3263–3266. 1998.PubMed/NCBI
|
|
32
|
Samaha HS, Kelloff GJ, Steele V, Rao CV
and Reddy BS: Modulation of apoptosis by sulindac, curcumin,
phenylethyl-3-methylcaffeate, and 6-phenylhexyl isothiocyanate:
Apoptotic index as a biomarker in colon cancer chemoprevention and
promotion. Cancer Res. 57:1301–1305. 1997.PubMed/NCBI
|
|
33
|
Sikora E, Bielak-Zmijewska A, Piwocka K,
Skierski J and Radziszewska E: Inhibition of proliferation and
apoptosis of human and rat T lymphocytes by curcumin, a curry
pigment. Biochem Pharmacol. 54:899–907. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chen HW and Huang HC: Effect of curcumin
on cell cycle progression and apoptosis in vascular smooth muscle
cells. Br J Pharmacol. 124:1029–1040. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Jee SH, Shen SC, Tseng CR, Chiu HC and Kuo
ML: Curcumin induces a p53-dependent apoptosis in human basal cell
carcinoma cells. J Invest Dermatol. 111:656–661. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Jagetia GC and Aggarwal BB: “Spicing up”
of the immune system by curcumin. J Clin Immunol. 27:19–35. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Bruck R, Ashkenazi M, Weiss S, Goldiner I,
Shapiro H, Aeed H, Genina O, Helpern Z and Pines M: Prevention of
liver cirrhosis in rats by curcumin. Liver Int. 27:373–383. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
El-Houseini ME, Refaei MO, Amin AI and
Abol-Ftouh MA: Potential role of curcumin and taurine combination
therapy on human myeloid leukemic cells propagated in vitro. Leuk
Lymphoma. 54:2281–2287. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Abdeen SH, El-Houseini ME, El-Sherbiny M,
Tabashy R and Salah A: Ex vivo assessment of the protective effect
of curcumin and taurine against human hepatocarcinogenesis. J Basic
Appl Zool. 66:180–187. 2013. View Article : Google Scholar
|
|
40
|
Leventhal, Ruth and Russell F Cheadle:
Medical parasitology: A Self-Instructional Text. FA Davis.
2011.
|
|
41
|
El-Houseini, ME, El-Sherbiny M, Awad, ME,
El-Din Awad M, Amer MA, El Din AH and Hussein TD: Serum
alpha-L-fucosidase enzyme activity as a marker for hepatocellular
carcinoma: Comparison with AFP using ROC analysis. J Egypt Natl
Cancer Inst. 13:227–283. 2001.
|
|
42
|
Bravman JC and Sinclair R: The preparation
of cross-section specimens for transmission electron microscopy. J
Electron Microsc Tech. 1:53–61. 1984. View Article : Google Scholar
|
|
43
|
Liu Y, Daley S, Evdokimova VN, Zdobinski
DD, Potter DM and Butterfield LH: Hierarchy of alpha fetoprotein
(AFP)-specific T cell responses in subjects with AFP-positive
hepatocellular cancer. J Immunol. 177:712–721. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Butterfield LH, Ribas A, Potter DM and
Economou JS: Spontaneous and vaccine induced AFP-specific T cell
phenotypes in subjects with AFP-positive hepatocellular cancer.
Cancer Immunol Immunother. 56:1931–1943. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Guo LY, Cai XF, Lee JJ, Kang SS, Shin EM,
Zhou HY, Jung JW and Kim YS: Comparison of suppressive effects of
demethoxycurcumin and bisdemethoxycurcumin on expressions of
inflammatory mediators in vitro and in vivo. Arch Pharm Res.
31:490–496. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Sandur SK, Pandey MK, Sung B, Ahn KS,
Murakami A, Sethi G, Limtrakul P, Badmaev V and Aggarwal BB:
Curcumin, demethoxycurcumin, bisdemethoxycurcumin,
tetrahydrocurcumin and turmerones differentially regulate
anti-inflammatory and anti-proliferative responses through a
ROS-independent mechanism. Carcinogenesis. 28:1765–1773. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Suryanarayana P, Satyanarayana A,
Balakrishna N, Kumar PU and Reddy GB: Effect of turmeric and
curcumin on oxidative stress and antioxidant enzymes in
streptozotocin-induced diabetic rat. Med Sci Monit. 13:BR286–BR292.
2007.PubMed/NCBI
|
|
48
|
Kunnumakkara AB, Diagaradjane P, Guha S,
Deorukhkar A, Shentu S, Aggarwal BB and Krishnan S: Curcumin
Sensitizes human colorectal cancer xenografts in nude mice to
gamma-radiation by targeting nuclear factor-kappaB-regulated gene
products. Clin Cancer Res. 14:2128–2136. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Lin J and Chen A: Activation of peroxisome
proliferator-activated receptor-gamma by curcumin blocks the
signaling pathways for PDGF and EGF in hepatic stellate cells. Lab
Invest. 88:529–540. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Waterfield CJ, Turton JA, Scales MD and
Timbrell JA: Taurine, a possible urinary marker of liver damage: A
study of taurine excretion in carbon tetrachloride-treated rats.
Arch Toxicol. 65:548–555. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Chen Y, Li S and Zhang X: Taurine inhibits
deposition of extracellular matrix in experimental liver fibrosis
in rats. Zhong Hua Gan Zang Bing Za Zhi. 7:165–167. 1999.(In
Chinese).
|
|
52
|
Wu QD, Wang JH, Fennessy F, Redmond HP and
Bouchier-Hayes D: Taurine prevents high-glucose-induced human
vascular endothelial cell apoptosis. Am J Physiol. 277:C1229–C1238.
1999.PubMed/NCBI
|
|
53
|
Dinçer S, Ozenirler S, Oz E, Akyol G and
Ozoğul C: The protective effect of taurine pretreatment on carbon
tetrachloride-induced hepatic damage-a light and electron
microscopic study. Amino Acids. 22:417–426. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Boujendar S, Arany E, Hill D, Remacle C
and Reusens B: Taurine supplementation of a low protein diet fed to
rat dams normalizes the vascularization of the fetal endocrine
pancreas. J Nutr. 133:2820–2825. 2003.PubMed/NCBI
|
|
55
|
Yoysungnoen P, Wirachwong P, Bhattarakosol
P, Niimi H and Patumraj S: Effects of curcumin on tumor
angiogenesis and biomarkers, COX-2 and VEGF, in hepatocellular
carcinoma cell-implanted nude mice. Clinical Hemorheol Microcirc.
109–115. 2006.
|
|
56
|
Tomova R, Pomakov J, Jacobs JJ, Adjarov D,
Popova S, Altankova I, Den Otter W and Krastev Z: Changes in
cytokine profile during local IL-2 therapy in cancer patients.
Anticancer Res. 26:2037–2047. 2006.PubMed/NCBI
|
|
57
|
Antony S, Kuttan R and Kuttan G:
Immunomodulatory activity of curcumin. Immunol Invest. 28:291–303.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Jagetia GC and Aggarwal BB: ‘Spicing up’
of the immune system by curcumin. J Clin Immunol. 27:19–35. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Yadav VS, Mishra KP, Singh DP, Mehrotra S
and Singh VK: Immunomodulatory effects of curcumin. Immunopharmacol
Immunotoxicol. 27:485–497. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Aggarwal BB, Surh YJ and Shishodia S: The
Molecular Targets and Therapeutic Uses of Curcumin in Health and
Disease. Springer Science+Business Media; 2007, View Article : Google Scholar
|
|
61
|
You JS and Chang KJ: Taurine protects the
liver against lipid peroxidation and membrane disintegration during
rat hepatocarcinogenesis. Adv Exp Med Biol. 442:105–112. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Redmond HP, Stapleton PP, Neary P and
Bouchier-Hayes D: Immunonutrition: The role of taurine. Nutrition.
14:599–604. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Kim H, Jeon H, Kong H, Yang Y, Choi B, Kim
YM, Neckers L and Jung Y: A molecular mechanism for the
anti-inflammatory effect of taurine-conjugated 5-aminosalicylic
acid in inflamed colon. Mol Pharmacol. 69:1405–1412. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Chorazy M, Kontny E, Marcinkiewicz J and
Maśliński W: Taurine chloramine modulates cytokine production by
human peripheral blood mononuclear cells. Amino Acids. 23:407–413.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
aziz MT Abdel, El Asmar MF, Atta HM,
Mahfouz S, Fouad HH, Roshdy NK, Rashed LA, Sabry D, Hassouna AA and
Taha FM: Efficacy of mesenchymal stem cells in suppression of
hepatocarcinorigenesis in rats: Possible role of Wnt signaling. J
Exp Clin Cancer Res. 30:492011. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Couch JA: Light and electron microscopic
comparisons of normal hepatocytes and neoplastic hepatocytes of
well-differentiated hepatocellular carcinomas in a teleost fish.
Dis Aquat Org. 16:1–14. 1993. View Article : Google Scholar
|
|
67
|
Aggarwal S, Ichikawa H, Takada Y, Sandur
SK, Shishodia S and Aggarwal BB: Curcumin (diferuloylmethane)
down-regulates expression of cell proliferation and antiapoptotic
and metastatic gene products through suppression of IkappaBalpha
kinase and Akt activation. Mol Pharmacol. 69:195–206.
2006.PubMed/NCBI
|
|
68
|
He SM, Li CG, Liu JP, Chan E, Duan W and
Zhou SF: Disposition pathways and pharmacokinetics of herbal
medicines in humans. Curr Med Chem. 17:4072–4113. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Aggarwal BB, Kumar A and Bharti AC:
Anticancer potential of curcumin: Preclinical and clinical studies.
Anticancer Res. 23:363–398. 2003.PubMed/NCBI
|
|
70
|
Koyama I, Nakamura T, Ogasawara M, Nemoto
M and Yoshida T: The protective effect of taurine on the
biomembrane against damage produced by the oxygen radical. Adv Exp
Med Biol. 315:355–359. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
El-Agamy DS: Comparative effects of
curcumin and resveratrol on aflatoxin B(1)-induced liver injury in
rats. Arch Toxicol. 84:389–396. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Tasci I, Mas N, Mas MR, Tuncer M and
Comert B: Ultrastructural changes in hepatocytes after taurine
treatment in CCl4 induced liver injury. World J Gastroenterol.
14:4897–4902. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
McCourt M, Wang JH, Sookhai S and Redmond
HP: Taurolidine inhibits tumor cell growth in vitro and in vivo.
Ann Surg Oncol. 7:685–691. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Calabresi P, Goulette FA and Darnowski JW:
Taurolidine: Cytotoxic and mechanistic evaluation of a novel
antineoplastic agent. Cancer Res. 61:6816–6821. 2001.PubMed/NCBI
|
|
75
|
Stendel R, Stoltenburg-Didinger G, Al
Keikh CL, Wattrodt M and Brock M: The effect of taurolidine on
brain tumor cells. Anticancer Res. 22:809–814. 2002.PubMed/NCBI
|
|
76
|
Petrovic L, Schlegel KA, Ries J, Park J,
Diebel E, Schultze-Mosgau S and Wiltfang J: In vitro effect of
taurolidine on squamous cell carcinoma in the oral cavity. Mund
Kiefer Gesichtschir. 7:102–107. 2003.(In German). View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Rodak R, Kubota H, Ishihara H, Eugster HP,
Könü D, Möhler H, Yonekawa Y and Frei K: Induction of reactive
oxygen intermediates-dependent programmed cell death in human
malignant ex vivo glioma cells and inhibition of the vascular
endothelial growth factor production by taurolidine. J Neurosurg.
102:1055–1068. 2005. View Article : Google Scholar : PubMed/NCBI
|
